NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Statement of Cash Flows
2026-04-01 to 2026-06-30
Statement of Cash Flows
2026-04-01 to 2026-06-30
Swipe to see the full flow
Chart details
NEUROCRINE BIOSCIENCES, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026
Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Mar 31, 2026
- 274,500,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 136,400,000 US dollars. Net cash provided.
- Net income
- 144,400,000 US dollars
- Stock-based compensation
- 65,000,000 US dollars
- Depreciation
- 8,400,000 US dollars
- Amortization of inventory fair-value step-up
- 3,000,000 US dollars
- Realized loss on sale of available-for-sale debt securities
- 5,200,000 US dollars
- Accretion of discount on available-for-sale debt securities, net
- negative 300,000 US dollars
- Amortization of acquired intangible assets
- 16,400,000 US dollars
- Changes in fair values of equity investments
- negative 1,200,000 US dollars
- Deferred income taxes
- negative 25,300,000 US dollars
- Accounts receivable
- negative 84,300,000 US dollars
- Inventory
- negative 6,500,000 US dollars
- Accounts payable and accrued liabilities
- negative 8,500,000 US dollars
- Income tax assets and liabilities
- negative 59,600,000 US dollars
- Other assets and liabilities, net
- 78,800,000 US dollars
- Non-cash lease expense
- 900,000 US dollars
- Gain on sale of business, net of transaction costs
- 0 US dollars
- Other
- 0 US dollars
- Investing activities
- negative 135,400,000 US dollars. Net cash used.
- Purchases of available-for-sale debt securities
- negative 37,400,000 US dollars
- Sales and maturities of available-for-sale debt securities
- 2,268,300,000 US dollars
- Acquisition of business, net of cash acquired
- negative 2,358,500,000 US dollars
- Capital expenditures
- negative 7,800,000 US dollars
- Proceeds from sale of business
- 0 US dollars
- Financing activities
- 63,400,000 US dollars. Net cash provided.
- Proceeds from borrowings under revolving credit facility
- 600,000,000 US dollars
- Repayments of borrowings under revolving credit facility
- negative 600,000,000 US dollars
- Payment of debt issuance costs
- negative 6,700,000 US dollars
- Issuances of common stock under benefit plans
- 84,800,000 US dollars
- Taxes paid related to net share settlement of equity awards
- negative 2,700,000 US dollars
- Repurchases of common stock
- negative 12,000,000 US dollars
- Operating adjustment reconciliation
- 185,700,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 684,800,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 2,403,700,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 0 US dollars
- Ending cash on Jun 30, 2026
- 338,900,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 474,300,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 64,400,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 0.94×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 136,400,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 7,800,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 128,600,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income exceeds operating cash. The diagram allocates $136.40M of net income directly to operating cash and $8.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 136,400,000 US dollars minus 7,800,000 US dollars equals 128,600,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!